1995
Unexpected borderline malignant and malignant smooth muscle cell tumors of the uterine corpus in women treated with LH-RH analogues
Publication
Publication
European Journal of Obstetrics & Gynecology and Reproductive Biology , Volume 62 - Issue 2 p. 257- 259
In this report, two cases of uterine smooth muscle cell tumors, one of uncertain malignant potential and one clearly malignant, are described in women treated for prolonged periods with luteinizing hormone-releasing hormone (LH-RH) analogues. Due to lengthy monitoring of LH-RH therapy, surgical intervention and histologic classification of these tumors was late in the course of disease, resulting in a delay in definite treatment. The risk to these women is discussed. The effects of LH-RH analogue therapy on fibroids is reviewed. Suggestions are put forward for monitoring LH-RH analogue therapy.
| Additional Metadata | |
|---|---|
| , , | |
| doi.org/10.1016/0301-2115(95)02192-A, hdl.handle.net/1765/71849 | |
| European Journal of Obstetrics & Gynecology and Reproductive Biology | |
| Organisation | Department of Pathology |
|
Wauters, C. C. A. P., ter Harmsel, B., Hermans, M. P. M., & Smedts, F. (1995). Unexpected borderline malignant and malignant smooth muscle cell tumors of the uterine corpus in women treated with LH-RH analogues. European Journal of Obstetrics & Gynecology and Reproductive Biology, 62(2), 257–259. doi:10.1016/0301-2115(95)02192-A |
|
